Medicine (Infectious Diseases and International Medicine)
Medical School
Twin Cities
Award Year
2024
University Award
Distinguished McKnight University Professors
, Location 15
Advancing therapeutics for COVID-19 and for HIV-related meningitis through clinical trials to impact global guidelines.
David Boulware is an infectious disease physician-scientist who has built a clinical research team focused on improving the diagnosis, treatment, and prevention of HIV- related meningitis in low and middle income countries. Early in the COVID-19 pandemic, Boulware stepped forward to create and lead a series of innovative remote, internet-based nationwide randomized clinical trials testing outpatient COVID-19 therapeutics. These trials informed international treatment guidelines for a number of medications, most notably hydroxychloroquine and ivermectin.